Annette Czernik, MD
Dermatology · Wilton, CTNPI 1346414497
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,477 of the $32,426 with a category attached, or 69.3%. 30 manufacturers reported payments, led by Sanofi at 42.2% of the total.
Across 258 payments — averaging $125.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$14K
- Regeneron$13K
- Regeneron Healthcare Solutions, Inc.$833
- Novartis$511
- Incyte Corporation$471
- Merz North America, Inc.$461
- plus $3K from 24 others
Across 2 payments — averaging $4209.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hoffmann-la Roche Limited$8K
- Principia Biopharma Inc.$425
What the payments were for
- Consulting fees$22,47769%
- Travel & lodging$3,57811%
- Food & beverage$6,12119%
- Education$2501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 30 | $13,685 |
| Regeneron | 12 | $13,374 |
| Regeneron Healthcare Solutions, Inc. | 34 | $833 |
| Novartis | 28 | $511 |
| Incyte Corporation | 21 | $471 |
| Merz North America, Inc. | 3 | $461 |
| Johnson & Johnson | 15 | $420 |
| AbbVie | 21 | $419 |
| Lilly USA, LLC | 13 | $334 |
| Galderma Laboratories, L.p. | 11 | $333 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $265 |
| UCB, Inc. | 10 | $240 |
| LEO Pharma Inc. | 10 | $226 |
| Amgen | 8 | $164 |
| Pfizer | 6 | $127 |
| Arcutis Biotherapeutics, Inc. | 5 | $105 |
| Sun Pharmaceutical Industries Inc. | 3 | $58 |
| Journey Medical Corporation | 3 | $53 |
| Boehringer Ingelheim | 2 | $51 |
| Mayne Pharma Commercial LLC | 3 | $50 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Botanix SB Inc | 1 | $30 |
| Dermavant Sciences, Inc. | 2 | $29 |
| Organon | 1 | $28 |
| Sensus Healthcare, Inc. | 1 | $25 |
| Revance Therapeutics, Inc. | 1 | $22 |
| LNHC, Inc | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,426 in reported general payments places this provider in the 85th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 25 | $110,337 |
| Dupixent PenDupilumab | 23 | $106,779 |
| Mycophenolate Mofetil | 19 | $4,600 |
| Clobetasol Propionate | 28 | $1,857 |
| Triamcinolone Acetonide | 41 | $660 |
| Fluorouracil | 11 | $584 |
| Ketoconazole | 39 | $583 |
| Desonide | 15 | $412 |
| Minoxidil | 34 | $403 |
| Prednisone | 37 | $341 |
| Doxycycline Hyclate | 17 | $283 |
| ValacyclovirValacyclovir Hcl | 15 | $217 |
| Hydroxyzine Hcl | 12 | $127 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wilton
- Michael PayetteCromwell$3.2M
- Bruce StroberCromwell$2.9M
- Brett KingFairfield$2.5M
- Mona ShahriariCromwell$2.2M
- Jeremy MossMadison$2M
- Brittany CraiglowFairfield$1.9M
- Meagen McCuskerEnfield$1.8M
- Marcus McFerrenOrange$872K
- Christopher BunickNew Haven$661K
- Keith ChoateNew Haven$362K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.